Cell & Gene
Therapy CTDMO
Contract Testing, Development,
and Manufacturing Services for Advanced Therapies.
Subscribe to our newsletter
Delivering the Future
of Medicine
We are a global contract testing, development and manufacturing organization, (CTDMO). We enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world. Our vision is that one day, every drug can be made, and every disease can be treated.
Learn More About Us
Innovative and Transformative Services
For more than 20 years, we have been working with pioneers in advanced therapies to help them successfully discover, develop, manufacture and release their products for patient use.
Contract Testing
Proven analytical method development, lot release testing, viral clearance, stability, and more.
Learn More
Process Development
Expert and flexible approaches to develop, scale, and optimize your processes and methods.
Learn More
IND Enabling Studies
Optimize processes, ensure GMP readiness, and secure data required for your IND submission.
Learn More
Clinical Manufacturing
Phase appropriate approaches that accelerate timelines and ensure quality clinical production.
Learn More
Commercial Manufacturing
High-quality, high-volume capacity, infrastructure, logistics, and systems which have passed inspection.
Learn More
Our
Capabilities
Expertise
Facilities
Quality
Regulatory
Supply Chain
Modalities and Therapeutic Areas
Our experience and services cover CAR-T, T-Cell, TIL, MSC, AAV, Lenti, mAbs, Vaccines and other common advanced therapies.
Autologous
Allogeneic
Monoclonal Antibodies
Vaccines
Viral Vectors
Articles & Events
WuXi ATU Sponsors the Believe Ball, Hosts Tom Whitehead, and Launches a Book Club Starting with Praying for Emily: The Faith, Science, and Miracles That Saved Our Daughter
WuXi Advanced Therapies had the immense honor of sponsoring this year’s Emily Whitehead Foundation Believe Ball, held on September 27th in Philadelphia. It was a night to remember, filled with hope, inspiration, and community. The event brought together industry leaders, supporters, and patient warriors who have fought and continue to fight for a future with better access to life-saving therapies